Professor Proochista Ariana is course director for the MSc in International Health and Tropical Medicine, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine. Her research empirically examines the relationship between processes of development and health in resource limited and transition contexts, appreciating the multidimensionality of both. Proochista holds a Masters in International Health from Harvard University and a Doctorate in International Development from University of Oxford, as well as a Post Graduate Diploma in Learning and Teaching in Higher Education, also from Oxford.

Recent publications:

• Comprehensive analysis of stroke epidemiology in Vietnam: Insights from GBD 1990–2019 and RES-Q 2017–2023. Tran MC. et al, (2025), Global Epidemiology, 9
• Is this pill an antibiotic or a painkiller? Improving the identification of oral antibiotics for better use Monnier AA. et al, (2023), The Lancet Global Health, 11, e1308 – e1313
• Seroepidemiology of Lassa virus in pregnant women in Southern Nigeria: A prospective hospital-based cohort study. Kayem ND. et al, (2023), PLoS neglected tropical diseases, 17
• Transplacental transfer of Lassa IgG antibodies in pregnant women in Southern Nigeria: A prospective hospital-based cohort study. Kayem ND. et al, (2023), PLoS neglected tropical diseases, 17
• Malaria patient spectrum representation in therapeutic clinical trials of uncomplicated malaria: a scoping review of the literature. Arena L. et al, (2023), Malaria journal, 22

Dr Phuong Le Tri is a surgeon and scientific researcher by training and has held various leadership positions at AstraZeneca across diverse medical fields, spanning Asia to the global level. He previously served as Chief Medical Officer cum Chief Representative at AstraZeneca Vietnam and has undertaken key roles for AstraZeneca.

He has extensive experience in developing and managing clinical and epidemiological research studies. Dr Phuong Le Tri possesses a strong educational foundation, having been trained in Neuroscience at Brussels UZB University Hospital (Vrije Universiteit Brussel), Belgium; the Tazuke Kofukai Kitano Medical Research Institute, Japan; and in Drug Development Science at King’s College London, United Kingdom.

Ernest Guevara is an independent public health consultant with over 20 years of experience in community and public health across humanitarian and low-resource settings. His career spans roles as a community health worker, medical doctor, and formerly the Head of Valid Measures—the metrics, analytics, and technology unit of Valid International.

He specializes in spatial epidemiology, geo-statistics, cartography, and statistical programming, and has led the development of innovative survey designs and analytical approaches using Bayesian and resampling methods.

Ernest is a founding member of Katilingban, a collective of public health and nutrition experts. He currently works as a consulting research data scientist with EcoHealth Alliance, supporting computational analytics for pandemic preparedness and One Health research, and serves as a Senior Research and Teaching Associate at the Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford.

Recent publications:

• Impact evaluation of the World Food Programme’s moderate acute malnutrition treatment and prevention programmes in Sudan 3ie Impact Evaluation Report (2018) Ernest Guevarra, Emmanuel Mandalazi, Safari Balegamire, Kristine Albrektsen, Kate Sadler, Khalid Abdelsalam, Gloria Urrea, Salma Alawad (2018).
• Household Coverage of Fortified Staple Food Commodities in Rajasthan, India. PLoS One Grant J. (2016) Aaron, Prahlad R. Sodani, Rajan Sankar, John Fairhurst, Katja Siling, Ernest Guevarra, Alison Norris, Mark Myatt.
• Assessing Program Coverage of Two Approaches to Distributing a Complementary Feeding Supplement to Infants and Young Children in Ghana. PLoS One (2016)  Grant J. Aaron, Nicholas Strutt, Nathaniel Amoh Boateng, Ernest Guevarra, Katja Siling, Alison Norris, Shibani Ghosh, Mercy Nyamikeh, Antoine Attiogbe, Richard Burns, Esi Foriwa, Yasuhiko Toride, Satoshi Kitamura, Kwaku Tano-Debrah, Daniel Sarpong, Mark Myatt.
• Assessing Coverage of Targeted and Large-scale Fortification Programs: Development of a Fortification Assessment Coverage Tool (FACT). Micronutrient Forum. (2015) Grant Aaron, Katja Siling, Alison Norris, Ernest Guevarra, Mark Myatt
• A single coverage estimator for use in SQUEAC, SLEAC, and other CMAM coverage assessments. Field Exchange (2015)  Safari Balegamire, Katja Siling, Jose Luis Alvarez, Ernest Guevarra, Sophie Woodhead, Alison Norris, Lionela Fieschi, Paul Binns, Mark Myatt.

Minh C. Tran is a biomedical engineer specializing in medical device development, healthcare systems, and cross-country regulatory and safety frameworks. He holds a degree in Software and Systems Engineering from the University of Sheffield (UK) and a DPhil in Engineering Science from the University of Oxford (UK).

At Oxford’s Nuffield Department of Clinical Neurosciences (NDCN), Minh worked with Professor Andrew Farmery, contributing to multidisciplinary research collaborations spanning Vietnam, New Zealand, the United States, and Taiwan.

He is a member of the International Stroke Recovery and Rehabilitation Alliance (ISRRA), the Oxford Stroke Recovery Research Hub, and currently serves as Chair of the Vietnam Young Academy.

Recent publications:

• Comprehensive analysis of stroke epidemiology in Vietnam: Insights from GBD 1990-2019 and RES-Q 2017-2023. Tran MC. et al, (2025), Glob Epidemiol, 9
• Prevalence of common autosomal recessive and X-linked conditions in pregnant women in Vietnam: a cross-sectional study. Nguyen TT. et al, (2025), Sci Rep, 15
• Early neurological deterioration in patients with minor stroke: A single-center study conducted in Vietnam. Nguyen DT. et al, (2025), PLOS One, 20, e0323700 – e0323700
• Noninvasive Measurement of Lung Function Using the Inspired Sinewave Technique in Mechanically Ventilated Patients With Acute Brain Injury: A Feasibility Study. Joseph A. et al, (2025), Anesthesia and Analgesia

Quyen D. Tran is a global health researcher specializing in vaccine policy, translational partnerships, and data-driven decision science. She holds an MSc in International Health and Tropical Medicine and an MBA from the University of Oxford. Quyen previously served as Global Health Translational Partnerships Manager at the University of Oxford and is currently a Life Science AI Decision Science Manager at Accenture UK & Ireland, where she supports research translation, innovation strategy, and analytical frameworks to strengthen health systems.

With over a decade of experience in the field, Dr. Chu currently works at Tam Anh Research Institute in Vietnam, where his work focuses on advancements in vaccination and cancer immunotherapy.

With more than ten years of experience in teaching, research, and clinical practice in Hematology–Oncology and Immunology, Dr. Chu Tan Huy (MD, PhD) is currently working at Tam Anh Research Institute and focuses on research into vaccines and immunotherapies for cancer treatment.

He has authored over 30 peer-reviewed publications in international journals indexed in the prestigious SCIE system. He also serves as an editor for international journals such as Frontiers in Immunology (immunology, SCIE Q1) and Frontiers in Oncology (oncology, SCIE Q2). In addition, he is a regular reviewer for many leading international journals (from SCIE Q1 to Q4).

He has received numerous awards throughout his studies and career, notable examples include: graduating as valedictorian of his PhD cohort at Chonnam National University (Korea); Best Presenter Award at the Hwasun Biomedical Workshop in 2017, 2018, 2019, 2020, and 2021; Best Presenter Award at the International Congress of Bone Marrow Transplantation, 2021; Contribution Award at the Korean Society of Hematology International Conference, 2021; Best Presenter Award at the 2024 Young Science and Technology Conference of Pham Ngoc Thach University of Medicine; and Best Presenter Award at the 2024 National Young Science and Technology Conference of the Health Sector.

Recent publications:

• Chu TH, Vo MC, Park HS, Lakshmi TJ, Jung SH, Kim HJ, et al. Potent anti-myeloma efficacy of dendritic cell therapy in combination with pomalidomide and programmed death-ligand 1 blockade in a preclinical model of multiple myeloma. Cancer Immunol Immunother. 2020.
• Vo MC, Ahn SY, Chu TH, Uthaman S, Pillarisetti S, Uong TNT, et al. A combination of immunoadjuvant nanocomplexes and dendritic cell vaccines in the presence of immune checkpoint blockade for effective cancer immunotherapy. Cell Mol Immunol. 2021;18(6):1599-601. (Co-first author)
• Chu TH, Vo MC, Lakshmi TJ, Ahn SY, Kim M, Song GY, et al. Novel IL-15 dendritic cells have a potent immunomodulatory effect in immunotherapy of multiple myeloma. Transl Oncol. 2022;20:101413.
• Chu TH, Jung SH, Kim K, Lee JH, Mun YC, Bang SM, et al. Relapse with plasmacytoma after upfront autologous stem cell transplantation in multiple myeloma. Ann Hematol. 2022;101(6):1217-26.
• Jung EK, Chu TH, Lee DH, Lee JK, et al. Natural killer cells have a synergistic anti-tumor effect in combination with chemoradiotherapy against head and neck cancer. Cytotherapy. 2022. (Corresponding author)
• Thangaraj JL, Ahn SY, Jung SH, Chu TH, et al. Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse model. Cell Mol Immunol. 2021.
• Vo MC, Lakshmi TJ, Jung SH, Cho D, Park HS, Chu TH, et al. Cellular immunotherapy in multiple myeloma. Korean J Intern Med. 2019;34(5):954-65.
• Vo MC, Yang S, Jung SH, Chu TH, et al. Synergistic Antimyeloma Activity of Dendritic Cells and Pomalidomide in a Murine Myeloma Model. Front Immunol. 2018;9:1798.
• Vo MC, Jung SH, Chu TH, Lee HJ, Lakshmi TJ, Park HS, et al. Lenalidomide and Programmed Death-1 Blockade Synergistically Enhances the Effects of Dendritic Cell Vaccination in a Model of Murine Myeloma. Front Immunol. 2018;9:1370.
• Thangaraj JL, Phan MT, Kweon S, Kim J, Chu TH, et al. Expansion of cytotoxic natural killer cells in multiple myeloma patients using K562 cells expressing OX40 ligand and membrane-bound IL-18 and IL-21. Cancer Immunol Immunother. 2021.

Dr. Huyen Dinh earned her Bachelor’s degree in Biology from Hanoi University of Science. She received the prestigious  Japanese Government MEXT scholarship and pursued her Master’s and Doctoral Degree in Energy Science, specializing in Biochemistry, at Kyoto University in Japan. She continued as an Assistant Professor at Kyoto University with Prof. Takashi Morii before moving to Humboldt University in Berlin, Germany as a postdoc researcher with Prof. Oliver Seitz.

With over a decade of international experience in both fundamental and applicational biochemical research. She has authored 18 research articles published in the field of chemistry and chemical biology. Her expertise spans advanced cell biology, microbiology, supramolecular nucleic acid structural techniques, and atomic force microscopy. Her recent topic covers DNA-peptide probe design for targeting and modulating oncogenic cell surface receptors.

Recent publications: 

• P. Ghosh, H. Dinh, A. Kocak, A. K Homer, P. Bou-Dip, S. Schlicht, O. Seitz, Angew. Chem. Int. Ed. 2025, 64, e202514237.
• P. Lin, T. Hayashi, H. Dinh, E. Nakata, M. Kinoshita, and T. Morii. Enzyme Reactions Are Accelerated or Decelerated When the Enzymes Are Located Near the DNA Nanostructure. ACS Applied Materials & Interfaces 2025 17 (10), 15775-15792
• P. Lin, H. Dinh, Y. Morita, E. Nakata, T. Morii. Dynamic Assembly of Cascade Enzymes by the Shape Transformation of a DNA Scaffold. Adv. Funct. Mater. 2023, 2215023.
• P. Lin, H. Dinh, E. Nakata, T. Morii. Dynamic Shape Transformation of a DNA Scaffold Applied for an Enzyme Nanocarrier. Front. Chem., 2021, 9
• H. Dinh, E. Nakata, K. Mutsuda-Zapater, M. Saimura, M. Kinoshita, T. Morii. Enhanced enzymatic activity exerted by a packed assembly of a single type of enzyme. Chem. Sci., 2020, 11, 9088-9100.
• T. A. Ngo, H. Dinh, T. M. Nguyen, F. F. Liew, E. Nakata, and T. Morii. DNA-binding proteins as the potential adaptors to locate functional protein on DNA nanoscaffold. Chem. Commun. 2019, 55, 12428 – 12446.
• H. Dinh, E. Nakata, P. Lin, M. Saimura, H. Ashida and T. Morii. Reaction of ribulose biphosphate carboxylase/oxygenase assembled on a DNA scaffold. Bioorg. Med. Chem. 2019, 27, 115120.